JAGX (Jaguar Health) Days Inventory : 1,639.80 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Jaguar Health Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Jaguar Health's Average Total Inventories for the three months ended in Dec. 2024 was $10.01 Mil. Jaguar Health's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.56 Mil. Hence, Jaguar Health's Days Inventory for the three months ended in Dec. 2024 was 1,639.80.

The historical rank and industry rank for Jaguar Health's Days Inventory or its related term are showing as below:

JAGX' s Days Inventory Range Over the Past 10 Years
Min: 261.65 Med: 617.99 Max: 2256.68
Current: 1784.26

During the past 12 years, Jaguar Health's highest Days Inventory was 2256.68. The lowest was 261.65. And the median was 617.99.

JAGX's Days Inventory is ranked worse than
94.88% of 644 companies
in the Biotechnology industry
Industry Median: 178.8 vs JAGX: 1784.26

Jaguar Health's Days Inventory increased from Dec. 2023 (1,166.72) to Dec. 2024 (1,639.80). It might indicate that Jaguar Health's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Jaguar Health's Inventory Turnover for the three months ended in Dec. 2024 was 0.06.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Jaguar Health's Inventory-to-Revenue for the three months ended in Dec. 2024 was 2.85.

Jaguar Health Days Inventory Historical Data

The historical data trend for Jaguar Health's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jaguar Health Days Inventory Chart

Jaguar Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

273.25

600.93

1,077.83

1,452.56

1,823.51

Jaguar Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Inventory	Get a 7-Day Free Trial															1,166.72	1,932.06	1,984.85	1,621.75	1,639.80

Competitive Comparison of Jaguar Health's Days Inventory

For the Biotechnology subindustry, Jaguar Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jaguar Health's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jaguar Health's Days Inventory distribution charts can be found below:

* The bar in red indicates where Jaguar Health's Days Inventory falls into.

Save Embed

;

Save Embed

;

Jaguar Health Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Jaguar Health's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (9.189	+	10.345)	/	2 )	/	1.955	*	365
=	9.767					/	1.955	*	365
=	1,823.51

Jaguar Health's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (9.674	+	10.345)	/	2 )	/	0.557	*	365 / 4
=	10.0095					/	0.557	*	365 / 4
=	1,639.80

Jaguar Health (NAS:JAGX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Jaguar Health's Inventory Turnover for the three months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.557	/	10.0095
	=	0.06

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Jaguar Health's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	10.0095	/	3.509
	=	2.85

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Jaguar Health Days Inventory Related Terms

Thank you for viewing the detailed overview of Jaguar Health's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Jaguar Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jaguar Health Inc (NAS:JAGX) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Pine Street, Suite 400, San Francisco, CA, USA, 94104

Website

http://www.jaguar.health

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Executives

Anula Jayasuriya	director	5150 EL CAMINO REAL, SUITE #A-32, LOS ALTOS CA 94022
Pravin R Chaturvedi	officer: Chief Scientific Officer	C/O JAGUAR HEALTH INC., 200 PINE STREET, SUITE 400, SAN FRANCISCO CA 94104
Lisa A Conte	director, officer: CEO & President	213 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Carol R. Lizak	officer: Chief Accounting Officer	201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105
James J Bochnowski	director	C/O DELPHI VENTURES, 160 BOVET RD, SUITE 408, SAN MATEO CA 94402
Jonathan S. Wolin	officer: Chief of Staff, CCO & GC	201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105
Jonathan B. Siegel	director	C/O KINGDON CAPITAL MANAGEMENT, L.L.C., 152 WEST 57TH STREET, 50TH FLOOR, NEW YORK NY 10019
Bryan Ezralow 1994 Trust Dated December 22, 1994	10 percent owner	23622 CALABASAS ROAD, SUITE 200, CALABASAS CA 91302
Bryan Ezralow	10 percent owner	THE EZRALOW CO, LLC, 23622 CALABASAS ROAD, SUITE 200, CALABASAS CA 91302-1549
Nantucket Investments Ltd	10 percent owner	PO BOX 282, REGENCY COURT, GLATEGNY ESPLANADE, ST PETER PORT Y7 GY1 3RH
Jonathan M Glaser	10 percent owner	11601 WILSHIRE BLVD., SUITE 2180, LOS ANGELES CA 90025
Murray David Macnaughtan	director	C/O JAGUAR HEALTH, INC., 201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105
Greg J Divis	director	10-1 BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN, DUBLIN L2 15
Jeffery C. Johnson	director	C/O SAGARD CAPITAL PARTNERS, L.P., 280 PARK AVENUE, 3F WEST, STAMFORD CT 06901
Sagard Capital Partners, L.p.	10 percent owner	280 PARK AVENUE, 3RD FLOOR WEST, NEW YORK NY 10017